PharmaCyte Biotech, Inc.
PMCB- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001157075
No open-market purchases or sales by PharmaCyte Biotech, Inc. insiders were filed in the last 90 days; 32 institutions reported holding it in 13F filings for Q2 2026, worth $586.2K in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, −3 vs. previous quarter
- 32
- 13F valueReported value at the end of Q2 2026
- $586.2K
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding PMCB, Q2 2026
No superinvestor reported holding PMCB at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by PharmaCyte Biotech, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 7, 2026 (view filing) | Jan 5-7 | 2 days | Silverman JoshuaCEO and President | PPurchase | +100.0K | $0.803 | +$80.3K | +31.6%416.3K after | 3 lots |
| Jan 7, 2026 (view filing) | Jan 5-7 | 2 days | Schechter JonathanDirector | PPurchase | +60.0K | $0.8033 | +$48.2K | +45.3%192.5K after | 3 lots |
Top 10 13F holders, Q2 2026
The largest institutional positions in PharmaCyte Biotech, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Citadel Advisors LLC | 283,381 | $218.2K | 0.00% | −76,166−21.2% | Reduced |
| Geode Capital Management, LLC | 124,247 | $95.7K | 0.00% | −71,413−36.5% | Reduced |
| Vanguard Capital Management LLC | 56,778 | $43.7K | 0.00% | +5,311+10.3% | Added |
| Susquehanna International Group, LLP | 44,853 | $34.5K | 0.00% | +44,853 | New |
| Renaissance Technologies LLC | 37,987 | $29.3K | 0.00% | −18,513−32.8% | Reduced |
| XTX Topco Ltd | 34,180 | $26.3K | 0.00% | −18,182−34.7% | Reduced |
| Northern Trust Corp | 32,624 | $25.1K | 0.00% | −2,977−8.4% | Reduced |
| Jane Street Group, LLC | 30,064 | $23.1K | 0.00% | +18,534+160.7% | Added |
| Schonfeld Strategic Advisors LLC | 26,926 | $20.7K | 0.00% | −83−0.3% | Reduced |
| Vanguard Fiduciary Trust Co | 23,452 | $18.1K | 0.00% | 00.0% | Unchanged |